The molecular diagnostics market is experiencing significant growth driven by advancements in technology, increasing demand for personalized medicine, and the rising prevalence of chronic diseases.

This study highlights lumican as a promising biomarker for predicting the onset and progression of diabetic nephropathy and ...

Akoya Biosciences, Inc.’s AKYA share price has dipped by 5.51%, which has investors questioning if this is right time to buy.

TissueGnostics introduced Tissue Cytometry technology into image analysis ... TissueQuest fully supports the analysis of Tissue Microarrays scanned either with TG TissueFAXS systems or those ...

Population genomics refers to the large-scale study of genetic variation both within and between populations of organisms, ...

Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that second quarter of fiscal year 2025 financial results will ...

Pioneering the ability to read the human genome at unprecedented speed and affordability, Illumina (NASDAQ:ILMN) develops and sells advanced DNA sequencing and microarray technologies ... Access our ...